Akshay S. Desai

55.4k total citations · 18 hit papers
386 papers, 21.2k citations indexed

About

Akshay S. Desai is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Akshay S. Desai has authored 386 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 306 papers in Cardiology and Cardiovascular Medicine, 87 papers in Endocrinology, Diabetes and Metabolism and 82 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Akshay S. Desai's work include Heart Failure Treatment and Management (252 papers), Cardiovascular Function and Risk Factors (155 papers) and Cardiac pacing and defibrillation studies (69 papers). Akshay S. Desai is often cited by papers focused on Heart Failure Treatment and Management (252 papers), Cardiovascular Function and Risk Factors (155 papers) and Cardiac pacing and defibrillation studies (69 papers). Akshay S. Desai collaborates with scholars based in United States, United Kingdom and Canada. Akshay S. Desai's co-authors include Scott D. Solomon, John J.V. McMurray, Jean L. Rouleau, Karl Swedberg, Michael R. Zile, Milton Packer, Victor Shi, Martin Lefkowitz, Adel R. Rizkala and Brian Claggett and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Akshay S. Desai

359 papers receiving 20.6k citations

Hit Papers

Angiotensin–Neprilysin Inhibition versus Enalapril in Hea... 2012 2026 2016 2021 2014 2012 2022 2012 2019 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
    2014 4.3k citations John J.V. McMurray, Milton Packer et al. profile →
  2. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
    2012 863 citations John J.V. McMurray, Scott D. Solomon et al. profile →
  3. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
    2022 491 citations Muthiah Vaduganathan, Kieran F. Docherty et al. profile →
  4. Rehospitalization for Heart Failure
    2012 460 citations Akshay S. Desai, Lynne W. Stevenson Circulation profile →
  5. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
    2019 401 citations Shannon M. Dunlay, Michael M. Givertz et al. Circulation profile →
  6. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
    2013 400 citations Karl Swedberg, Inder S. Anand et al. profile →
  7. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
    2017 382 citations Scott D. Solomon, Akshay S. Desai et al. profile →
  8. Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)
    2013 339 citations John J.V. McMurray, Milton Packer et al. European Journal of Heart Failure profile →
  9. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
    2016 337 citations Adriaan A. Voors, Akshay S. Desai et al. profile →
  10. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
    2015 335 citations Scott D. Solomon, Brian Claggett et al. profile →
  11. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
    2015 302 citations Akshay S. Desai, John J.V. McMurray et al. profile →
  12. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
    2018 291 citations Brian Claggett, Pardeep S. Jhund et al. JACC Heart Failure profile →
  13. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
    2019 224 citations Akshay S. Desai, Scott D. Solomon et al. profile →
  14. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
    2023 149 citations Akshay S. Desai et al. profile →
  15. Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
    2023 129 citations Jawad H. Butt, Mark C. Petrie et al. profile →
  16. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
    2023 81 citations Robert J. Mentz, Adrian F. Hernandez et al. Journal of the American College of Cardiology profile →
  17. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction
    2024 37 citations Michael R. Zile, Akshay S. Desai et al. Journal of the American College of Cardiology profile →
  18. Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
    2025 35 citations Muthiah Vaduganathan, Brian Claggett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akshay S. Desai United States 71 16.9k 4.7k 3.8k 2.3k 1.6k 386 21.2k
Brian Claggett United States 74 12.4k 0.7× 4.0k 0.8× 3.1k 0.8× 2.3k 1.0× 1.5k 0.9× 550 19.4k
Muthiah Vaduganathan United States 64 12.4k 0.7× 4.0k 0.9× 2.4k 0.6× 2.7k 1.2× 1.5k 0.9× 625 19.2k
Inder S. Anand United States 81 17.6k 1.0× 2.7k 0.6× 3.0k 0.8× 2.9k 1.3× 1.6k 1.0× 420 23.2k
Javed Butler United States 59 11.4k 0.7× 2.7k 0.6× 2.4k 0.6× 2.1k 0.9× 2.2k 1.4× 406 16.0k
Robert J. Mentz United States 63 9.9k 0.6× 4.2k 0.9× 2.3k 0.6× 2.5k 1.1× 1.7k 1.0× 579 15.7k
Michel Komajda France 77 22.2k 1.3× 4.2k 0.9× 2.6k 0.7× 2.5k 1.1× 3.9k 2.4× 355 26.8k
Carolyn S.P. Lam Singapore 86 22.3k 1.3× 6.1k 1.3× 4.6k 1.2× 3.7k 1.6× 3.1k 1.9× 567 30.0k
Eldrin F. Lewis United States 56 7.4k 0.4× 3.3k 0.7× 2.2k 0.6× 3.7k 1.6× 2.0k 1.2× 223 16.8k
Sanjiv J. Shah United States 80 17.7k 1.1× 3.6k 0.8× 5.3k 1.4× 2.9k 1.3× 3.1k 1.9× 638 25.5k
Giuseppe Rosano Italy 59 11.1k 0.7× 4.3k 0.9× 1.7k 0.4× 2.7k 1.2× 2.1k 1.3× 307 18.2k

Countries citing papers authored by Akshay S. Desai

Since Specialization
Citations

This map shows the geographic impact of Akshay S. Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akshay S. Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akshay S. Desai more than expected).

Fields of papers citing papers by Akshay S. Desai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akshay S. Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akshay S. Desai. The network helps show where Akshay S. Desai may publish in the future.

Co-authorship network of co-authors of Akshay S. Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Akshay S. Desai. A scholar is included among the top collaborators of Akshay S. Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akshay S. Desai. Akshay S. Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondo, Toru, Pardeep S. Jhund, Inder S. Anand, et al.. (2025). Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF. JACC Heart Failure. 13(6). 927–939. 2 indexed citations
2.
Ostrominski, John W., Mats Christian Højbjerg Lassen, Jawad H. Butt, et al.. (2025). Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. Journal of the American College of Cardiology. 86(20). 1760–1777. 2 indexed citations
3.
Neuen, Brendon L., Muthiah Vaduganathan, Brian Claggett, et al.. (2024). Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 13(1). 28–39. 8 indexed citations
4.
Desai, Akshay S., et al.. (2024). Falling liquid films on a uniformly heated compliant substrate with broken time-reversal symmetry. Journal of Fluids and Structures. 125. 104064–104064. 3 indexed citations
5.
Chatur, Safia, Iris E. Beldhuis, Brian Claggett, et al.. (2024). Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2. JACC Heart Failure. 12(10). 1692–1703. 5 indexed citations
6.
Lu, Henri, Brian Claggett, Milton Packer, et al.. (2024). Race in Heart Failure. JACC Heart Failure. 13(1). 58–71.
7.
Foà, Alberto, Muthiah Vaduganathan, Brian Claggett, et al.. (2024). Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction. Journal of the American College of Cardiology. 83(18). 1731–1739. 3 indexed citations
8.
Butt, Jawad H., John J.V. McMurray, Brian Claggett, et al.. (2024). Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant–Level Analysis of 6 Randomized Clinical Trials. Circulation. 150(23). 1858–1868. 3 indexed citations
9.
Reeder, Christopher, Brian Claggett, Pulkit Singh, et al.. (2024). Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials. Circulation Heart Failure. 18(1). e012514–e012514. 1 indexed citations
10.
Desai, Akshay S., et al.. (2023). Shear imposed falling liquid films on a slippery substrate with Marangoni effects: Effect of odd viscosity. International Journal of Non-Linear Mechanics. 156. 104507–104507. 8 indexed citations
11.
Tolomeo, Paolo, Jawad H. Butt, Toru Kondo, et al.. (2023). Independent Prognostic Importance of Blood Urea Nitrogen to Creatinine Ratio in Heart Failure. European Journal of Heart Failure. 26(2). 245–256. 12 indexed citations
12.
Chatur, Safia, Jonathan W. Cunningham, Muthiah Vaduganathan, et al.. (2023). Renal and Blood Pressure Effects of Dapagliflozin in Recently Hospitalized Patients with Heart Failure with mildly reduced or Preserved Ejection Fraction: Insights from the DELIVER Trial. European Journal of Heart Failure. 25(7). 1170–1175. 15 indexed citations
13.
Gelfand, Samantha L., Joshua R. Lakin, Ernest I. Mandel, et al.. (2022). Specialty-Aligned Palliative Care: Responding to the Needs of a Tertiary Care Health System. Journal of Pain and Symptom Management. 64(6). e341–e346. 10 indexed citations
14.
Ehteshami‐Afshar, Solmaz, Leanne Mooney, Pooja Dewan, et al.. (2021). Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF. Journal of the American Heart Association. 10(4). e019238–e019238. 27 indexed citations
15.
Dunlay, Shannon M., Michael M. Givertz, David Aguilar, et al.. (2019). Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. Journal of Cardiac Failure. 25(8). 584–619. 89 indexed citations
16.
Castro, Renata Rodrigues Teixeira de, Emer Joyce, Neal K. Lakdawala, et al.. (2019). Patients report more severe daily limitations than recognized by their physicians. Clinical Cardiology. 42(12). 1181–1188. 4 indexed citations
17.
Cappola, Anne Rentoumis, Akshay S. Desai, Marco Medici, et al.. (2019). Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment. Thyroid. 29(6). 760–777. 62 indexed citations
18.
Chandra, Alvin, Eldrin F. Lewis, Brian Claggett, et al.. (2018). Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure. JAMA Cardiology. 3(6). 498–498. 75 indexed citations
19.
Mogensen, Ulrik M., Pardeep S. Jhund, Lars Køber, et al.. (2016). Abstract 17986: Is There Really an “Obesity Paradox” in Heart Failure? An Analysis of PARADIGM-HF. Circulation. 2 indexed citations
20.
Sands, Scott A., Bradley A. Edwards, Shamim Nemati, et al.. (2016). Resonance as the Mechanism of Daytime Periodic Breathing in Patients with Heart Failure. American Journal of Respiratory and Critical Care Medicine. 195(2). 237–246. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Claggett Breakdown of academic impact, for papers by Muthiah Vaduganathan Breakdown of academic impact, for papers by Inder S. Anand Breakdown of academic impact, for papers by Javed Butler Breakdown of academic impact, for papers by Robert J. Mentz Breakdown of academic impact, for papers by Michel Komajda Breakdown of academic impact, for papers by Carolyn S.P. Lam Breakdown of academic impact, for papers by Eldrin F. Lewis Breakdown of academic impact, for papers by Sanjiv J. Shah Breakdown of academic impact, for papers by Giuseppe Rosano
Rankless by CCL
2026